Department of Surgery, Division of Urology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Int Urol Nephrol. 2024 Jan;56(1):63-67. doi: 10.1007/s11255-023-03772-1. Epub 2023 Sep 5.
The necessity of nephrostomy tube after percutaneous nephrolithotomy (PCNL) has been called into question in modern series. We sought to examine differences in postoperative complications and outcomes of tubeless PCNL versus standard PCNL at our institution.
A retrospective review of our institutional stone database was conducted from January 2016 to December 2021 for patients who had undergone either tubeless PCNL, defined by placement of only an internal ureteral stent, or standard PCNL, which involved placement of an externalized nephrostomy tube. Patients were excluded if they underwent totally tubeless PCNL.
A total of 438 patients were included for analysis: 329 patients underwent tubeless PCNL and 109 patients underwent standard PCNL. Between tubeless and standard groups, there was no difference in readmission rates 6.1% vs. 9.2% (p = 0.268), Clavien 2 or > complications 18.5% vs. 19.3% (p = 0.923), and Clavien 3 or > complications 4.0% vs. 7.3% (p = 0.151). The tubeless group experienced shorter operative duration 121.5 vs. 144.8 min (p = 0.012), shorter length of stay 2.5 vs. 3.8 days (p = 0.002), and higher stone-free rates 72.3% vs. 60.2% (p = 0.014), but also increased blood transfusion rates 6.4% vs. 0.9% (p = 0.022).
In comparing tubeless with standard PCNL, there was no difference in readmission rates, or significant Clavien complication rates. Patients undergoing tubeless PCNL experienced higher stone-free rates, but more number of patients required postoperative blood transfusion. The decision to leave a nephrostomy tube after PCNL appears unlikely to impact overall complication rates and can be left to surgeon experience and case-based discretion.
经皮肾镜碎石取石术(PCNL)后放置肾造瘘管的必要性在现代系列研究中受到质疑。我们旨在检查我院无管化 PCNL 与标准 PCNL 的术后并发症和结局的差异。
对 2016 年 1 月至 2021 年 12 月期间接受无管化 PCNL(仅放置内置输尿管支架)或标准 PCNL(放置外置肾造瘘管)的患者的机构结石数据库进行回顾性分析。如果患者接受了完全无管化 PCNL,则将其排除在外。
共纳入 438 例患者进行分析:329 例患者接受无管化 PCNL,109 例患者接受标准 PCNL。无管化组和标准组之间的再入院率分别为 6.1%和 9.2%(p=0.268),Clavien 2 或更高并发症发生率分别为 18.5%和 19.3%(p=0.923),Clavien 3 或更高并发症发生率分别为 4.0%和 7.3%(p=0.151)。无管化组的手术时间更短(121.5 分钟 vs. 144.8 分钟,p=0.012),住院时间更短(2.5 天 vs. 3.8 天,p=0.002),结石清除率更高(72.3% vs. 60.2%,p=0.014),但术后输血率更高(6.4% vs. 0.9%,p=0.022)。
在比较无管化与标准 PCNL 时,再入院率或显著的 Clavien 并发症发生率没有差异。接受无管化 PCNL 的患者结石清除率更高,但更多的患者需要术后输血。PCNL 后是否留置肾造瘘管似乎不会影响总体并发症发生率,可以根据外科医生的经验和具体情况来决定。